How a T1D advocate turned a personal battle into community change—and how you can too.
From tubeless pumps to a dual glucose-ketone sensor and cell therapy breakthroughs—ADA 2025 delivered game-changing updates in diabetes tech. Here's what stood out and who I spoke with to break it all down.
T1D travel tips, insulin packing advice, and real-world stories from long-term travelers—plus links to our ultimate diabetes travel guide and expert educator insights.
My Diabetes Educator shares expert tips for traveling confidently with diabetes, from packing to navigating air travel and insulin treatment on vacation.
After hearing your stories, we brought in experts—and spoke to Dexcom—to unpack what’s going on with Dexcom G7 sensor failures.
This early pioneer was certain CGM technology would improve patient lives when others doubted her.
Glucotrack is working on a 3-year CGM implant that measures glucose directly from the blood.
This inhalable insulin enters the system faster and leaves the body sooner, making it a great option for treatment for people with diabetes.
I ask Dexcom CEO, Kevin Sayer, your questions about Dexcom G7 and the future of continuous glucose monitor technology.
